Showing results (2751-2760 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|August 22, 2009
One-year assessment of joint procurement of pharmaceuticals in the public health sector in JordanIbrahim Al-Abbadi, Abdelraouf Qawwas, Mahmoud Jaafreh, et al.Clinical Therapeutics|August 22, 2009
Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient settingNancy M Yoon, Melissa K Cavaghan, Rocco L Brunelle, et al.Clinical Therapeutics|August 22, 2009
Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in ThailandSuda Vannaprasaht, Susothorn Angsuthum, Yingyos Avihingsanon, et al.Clinical Therapeutics|August 22, 2009
Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysisAhmed H Abdelhafiz, Min P Myint, John A Tayek, et al.Clinical Therapeutics|August 25, 2009
A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophreniaJoshua T Kantrowitz, Leslie Citrome, Daniel C JavittClinical Therapeutics|August 25, 2009
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysisLiberty Fajutrao, Björn Paulsson, Sherry Liu, et al.Clinical Therapeutics|March 1, 1991
Nitrendipine does not impair long-term glucose control in hypertensive noninsulin-dependent diabetic patientsF Giuntoli, F Galeone, S Gabbani, et al.Clinical Therapeutics|July 1, 1991
Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trialR R Khajotia, N Vetter, H HarazinClinical Therapeutics|July 1, 1991
Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertensionM C Lueg, J Herron, S ZellnerClinical Therapeutics|July 1, 1991
Nicardipine in the treatment of outpatients with cerebrovascular disordersR Lozano, A BalaguerPageof 678